Genetic polymorphisms of carcinogen metabolizing enzymes are associated with oral leukoplakia development and p53 overexpression

Anticancer Research

Volumn 28, Issue 2 A, 2008, Pages 1101-1106

  Duarte, Eliza Carla Barroso ^a   Ribeiro, Daniela Cotta ^a   Gomez, Marcus Vinícius ^a   Ramos Jorge, Maria Letícia ^a   Gomez, Ricardo Santiago ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Genetic polymorphisms; Oral leukoplakia; p53

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; CYTOCHROME P450 REDUCTASE; ENZYME; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; PARAFFIN; PROTEIN P53;

ADULT; ARTICLE; BRAZIL; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DIGESTION; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING;

BRAZIL; CARCINOGENS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOPLAKIA, ORAL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SMOKING;

EID: 42549167966     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Axell T, Pindborg JJ, Smith CJ and van der Waal I: Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 25(2): 49-54, 1996.
2. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52(4): 195-215, 2002.
3. Johnson NW, Warnakulasuriya S and Tavassoli M: Hereditary and environmental risk factors; clinical and laboratory risk matters for head and neck, especially oral, cancer and precancer. Eur J Cancer 5: 5-17, 1996.
4. Silverman S Jr, Gorsky M and Lozada F: Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 53(3): 563-568, 1984.
5. Burkhardt A: Advanced methods in the evaluation of premalignant lesions and carcinomas of the oral mucosa. J Oral Pathol 14(10): 751-778, 1985.
6. Lumerman H, Freedman P and Kerpel S: Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(3): 321-329, 1995.
7. Van der Waal I, Schepman KP, van der Meij EH and Smeele LE: Oral leukoplakia: a clinicopathological review. Oral Oncol 33(5): 291-301, 1997.
8. Bouquot JE, Weiland LH and Kurland LT: Leukoplakia and carcinoma in situ synchronously associated with invasive oral/oropharyngeal carcinoma in Rochester, Minn., 1935-1984. Oral Surg Oral Med Oral Pathol 65(2): 199-207, 1988.
9. Schepman K, der Meij E, Smeele L and der Waal I: Concomitant leukoplakia in patients with oral squamous cell carcinoma. Oral Dis 5(3): 206-209, 1999.
10. Lind PO: Malignant transformation in oral leukoplakia. Scand J Dent Res 95(6): 449-455, 1987.
11. Schepman KP, van der Meij EH, Smeele LE and van der Waal I: Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 34(4): 270-275, 1998.
12. Greenblatt MS, Bennett WP, Hollstein M and Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54(18): 4855-4878, 1994.
13. Raybaud-Diogene H, Tetu B, Morency R, Fortin A and Monteil RA: p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32B(3): 143-149, 1996.
14. Cruz I, Napier SS, van der Waal I, Snijders PJ, Walboomers JM, Lamey PJ, Cowan CG, Gregg TA, Maxwell P and Meijer CJ: Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol 55(2): 98-104, 2002.
15. Kurokawa H, Matsumoto S, Murata T, Yamashita Y, Tomoyose T, Zhang M, Fukuyama H and Takahashi T: Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia. J Oral Pathol Med 32(9): 513-521, 2003.
16. Sato M, Sato T, Izumo T and Amagasa T: Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer. Carcinogenesis 20(10): 1927-1931, 1999.
17. Lazarus P and Park JY: Metabolizing enzyme genotype and risk for upper aerodigestive tract cancer. Oral Oncol 36(5): 421-431, 2000.
18. Park JY, Muscat JE, Ren Q, Schantz SP, Harwick RD, Stern JC, Pike V, Richie JP and Lazarus P: CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 6(10): 791-797.
19. Sato M, Sato T, Izumo T and Amagasa T: Genetically high susceptibility to oral squamous cell carcinoma in terms of combined genotyping of CYP1A1 and GSTM1 genes. Oral Oncol 36(3): 267-271, 2000.
20. Garte S, Gaspari L, Alexandrie AK, Ambrosone C et al: Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10(12): 1239-1248, 2001.
21. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR and Pillai MR: Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37(7): 593-598, 2001.
22. Kao SY, Wu CH, Lin SC, Yap SK, Chang CS, Wong YK, Chi LY and Liu TY: Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J Oral Pathol Med 31(9): 505-511, 2002.
23. Drummond SN, De Marco L, Noronha JC and Gomez RS: GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol 40(1): 52-55, 2004.
24. Drummond SN, Gomez RS, Motta Noronha JC, Pordeus IA, Barbosa AA and De Marco L: Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects. Oral Oncol 41(5): 515-519, 2005.
25. Nair UJ, Nair J, Mathew B and Bartsch H: Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 20(5): 743-748, 1999.
26. Duarte EC, da Silva MS, Gomez MV and Gomez RS: GSTM1 polymorphism and oral leukoplakia. J Oral Pathol Med 35(4): 202-205, 2006.
27. Duarte EC, Da Silva MS, Gomez MV and Gomez RS: GSTT1 polymorphism and oral leukoplakia. Anticancer Res 26(1A): 427-430, 2006.
28. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM and Pena SD: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 100(1): 177-182, 2003.
29. Boom R, Sol CJ, Salimans MM, Jansen CL, Wertheim-van Dillen PM and van der Noordaa J: Rapid and simple method for purification of nucleic acids. J Clin Microbiol 28(3): 495-503, 1990.
30. Iamaroon A, Khemaleelakul U, Pongsiriwet S and Pintong J: Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma. J Oral Pathol Med 33(1): 30-36, 2004.
31. Fan GK, Chen J, Ping F and Geng Y: Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues. Oral Oncol 42(2): 147-153, 2006.
32. Geisler SA and Olshan AF: GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: a mini-HuGE review. Am J Epidemiol 154(2): 95-105, 2001.
33. Gronau S, Koenig-Greger D, Jerg M and Riechelmann H: Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg 128(5): 674-680, 2003.
34. Gudmundsdottir K, Tryggvadottir L and Eyfjord JE: GSTM1, GSTT1, and GSTP1 genotypes in relation to breast cancer risk and frequency of mutations in the p53 gene. Cancer Epidemiol Biomarkers Prev 10(11): 1169-1173, 2001.
35. Murti PR, Warnakulasuriya KA, Johnson NW, Bhonsle RB, Gupta PC, Daftary DK and Mehta FS: p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 27(5): 191-196, 1998.